The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miles, J. J.
Right arrow Articles by Burrows, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miles, J. J.
Right arrow Articles by Burrows, S. R.
The Journal of Immunology, 2006, 177: 6804-6814.
Copyright © 2006 by The American Association of Immunologists, Inc.

TCR{alpha} Genes Direct MHC Restriction in the Potent Human T Cell Response to a Class I-Bound Viral Epitope1

John J. Miles2,*,{dagger}, Natalie A. Borg2,{ddagger}, Rebekah M. Brennan*, Fleur E. Tynan{ddagger}, Lars Kjer-Nielsen§, Sharon L. Silins*, Melissa J. Bell*, Jacqueline M. Burrows*, James McCluskey§, Jamie Rossjohn3,{ddagger} and Scott R. Burrows3,*

* Cellular Immunology Laboratory, Queensland Institute of Medical Research, Brisbane, Australia; {dagger} School of Population Health, University of Queensland, Brisbane, Australia; {ddagger} The Protein Crystallography Unit, Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Australia; and § Department of Microbiology and Immunology, University of Melbourne, Parkville, Australia

The underlying generic properties of {alpha}β TCRs that control MHC restriction remain largely unresolved. To investigate MHC restriction, we have examined the CTL response to a viral epitope that binds promiscuously to two human leukocyte Ags (HLAs) that differ by a single amino acid at position 156. Individuals expressing either HLA-B*3501 (156Leucine) or HLA-B*3508 (156Arginine) showed a potent CTL response to the 407HPVGEADYFEY417 epitope from EBV. Interestingly, the response was characterized by highly restricted TCR β-chain usage in both HLA-B*3501+ and HLA-B*3508+ individuals; however, this conserved TRBV9+ β-chain was associated with distinct TCR {alpha}-chains depending upon the HLA-B*35 allele expressed by the virus-exposed host. Functional assays confirmed that TCR {alpha}-chain usage determined the HLA restriction of the CTLs. Structural studies revealed significant differences in the mobility of the peptide when bound to HLA-B*3501 or HLA-B*3508. In HLA-B*3501, the bulged section of the peptide was disordered, whereas in HLA-B*3508 the bulged epitope adopted an ordered conformation. Collectively, these data demonstrate not only that mobile MHC-bound peptides can be highly immunogenic but can also stimulate an extremely biased TCR repertoire. In addition, TCR {alpha}-chain usage is shown to play a critical role in controlling MHC restriction between closely related allomorphs.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC), the Roche Organ Transplantation Research Fund, the Juvenile Diabetes Research Foundation, and the Australian Research Council. N.A.B. is a recipient of an NHMRC Peter Doherty Research Fellowship, S.R.B. is a recipient of an NHMRC Career Development award, and J.R. is an Australian Research Council Federation Fellow.

2 J.J.M. and N.A.B. contributed equally to this work.

3 Address correspondence and reprint requests to Dr. Scott R. Burrows, Cellular Immunology Laboratory, Queensland Institute of Medical Research, Brisbane, Queensland 4029, Australia. E-mail address: Scott.Burrows{at}qimr.edu.au or Prof. Jamie Rossjohn, The Protein Crystallography Unit, Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria 3800, Australia, E-mail: Jamie.Rossjohn{at}med.monash.edu.au

4 Abbreviations used in this paper: pMHC-I, peptide-MHC complex class I; HPVG, 11-mer EBV peptide HPVGEADYFEY; TRBV, TCR β-chain variable.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Derre, M. Bruyninx, P. Baumgaertner, M. Ferber, D. Schmid, A. Leimgruber, V. Zoete, P. Romero, O. Michielin, D. E. Speiser, et al.
Distinct sets of {alpha}{beta} TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues
PNAS, September 30, 2008; 105(39): 15010 - 15015.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. K. Wynn, Z. Fulton, L. Cooper, S. L. Silins, S. Gras, J. K. Archbold, F. E. Tynan, J. J. Miles, J. McCluskey, S. R. Burrows, et al.
Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection
Blood, April 15, 2008; 111(8): 4283 - 4292.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. M. Brennan, J. J. Miles, S. L. Silins, M. J. Bell, J. M. Burrows, and S. R. Burrows
Predictable {alpha}{beta} T-Cell Receptor Selection toward an HLA-B*3501-Restricted Human Cytomegalovirus Epitope
J. Virol., July 1, 2007; 81(13): 7269 - 7273.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.